{"entity":{"type":"insider","cik":"0001815042","url":"/insider/0001815042","json_url":"/insider/0001815042.json","name":"Rajah Vignesh","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2020-12-04","last":"2024-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Rajah Vignesh","source":"filing","n_filings":4,"first_seen":"2020-12-04","last_seen":"2024-03-07"}],"transactions":[{"id":2962822,"accession":"0001104659-24-031942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-031942","line_url":"/filing/0001104659-24-031942#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001815042","owner_name":"Rajah Vignesh","owner_display_name":"Rajah Vignesh","owner_url":"/insider/0001815042","role":"Officer (SVP & CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (SVP & CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1711.0,"shares_display":"1,711","price_per_share":16.53,"price_display":"16.53","price_state":"stated","total_value":28282.83,"total_display":"28,282.83","total_whole":"28,283","shares_owned_after":33889.0,"shares_owned_after_display":"33,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":6307821,"accession":"0001104659-22-119642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-119642","line_url":"/filing/0001104659-22-119642#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001815042","owner_name":"Rajah Vignesh","owner_display_name":"Rajah Vignesh","owner_url":"/insider/0001815042","role":"Officer (SVP & CMO)","role_mark":"O","role_mark_label":"Officer (SVP & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1195.0,"shares_display":"1,195","price_per_share":4.924,"price_display":"4.92","price_state":"stated","total_value":5884.18,"total_display":"5,884.18","total_whole":"5,884","shares_owned_after":4266.0,"shares_owned_after_display":"4,266","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-16","scope":"insider"},{"id":4312423,"accession":"0001104659-21-105267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-105267","line_url":"/filing/0001104659-21-105267#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001815042","owner_name":"Rajah Vignesh","owner_display_name":"Rajah Vignesh","owner_url":"/insider/0001815042","role":"Officer (SVP & CMO)","role_mark":"O","role_mark_label":"Officer (SVP & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1374.0,"shares_display":"1,374","price_per_share":29.947,"price_display":"29.95","price_state":"stated","total_value":41147.178,"total_display":"41,147.18","total_whole":"41,147","shares_owned_after":3071.0,"shares_owned_after_display":"3,071","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-13","scope":"insider"},{"id":2425180,"accession":"0001104659-20-132538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-132538","line_url":"/filing/0001104659-20-132538#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001815042","owner_name":"Rajah Vignesh","owner_display_name":"Rajah Vignesh","owner_url":"/insider/0001815042","role":"Officer (SVP and CMO)","role_mark":"O","role_mark_label":"Officer (SVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":233.0,"shares_display":"233","price_per_share":51.03,"price_display":"51.03","price_state":"stated","total_value":11889.99,"total_display":"11,889.99","total_whole":"11,890","shares_owned_after":1697.0,"shares_owned_after_display":"1,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-04","scope":"insider"},{"id":2425177,"accession":"0001104659-20-132538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-132538","line_url":"/filing/0001104659-20-132538#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001815042","owner_name":"Rajah Vignesh","owner_display_name":"Rajah Vignesh","owner_url":"/insider/0001815042","role":"Officer (SVP and CMO)","role_mark":"O","role_mark_label":"Officer (SVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1464.0,"shares_display":"1,464","price_per_share":45.74,"price_display":"45.74","price_state":"stated","total_value":66963.36,"total_display":"66,963.36","total_whole":"66,963","shares_owned_after":1464.0,"shares_owned_after_display":"1,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-12-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722964","name":"Y-mAbs Therapeutics, Inc.","url":"/issuer/0001722964","role":"Officer (SVP & CHIEF MEDICAL OFFICER)","n_filings":4,"first_seen":"2020-12-04","last_seen":"2024-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001815042","retrieved_at":"2026-08-25T04:26:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}